合并深静脉反流对主干静脉腔内消融结局的影响:Vascular Quality Initiative 研究
基于 Vascular Quality Initiative 2015–2019 年数据,纳入 4881 例接受主干静脉腔内消融的患者,其中 2254 例(46.2%)合并深静脉反流。合并深静脉反流者症状总改善无显著差异,但 VCSS 改善更大,并发症发生率显著更高,尤其近端血栓延伸。
要点
- 合并深静脉反流者消融后症状总评分改善与无深静脉反流者无差异。
- 合并深静脉反流者并发症发生率更高(10.4% vs 3.0%),近端血栓延伸更常见。
- 术前应告知合并深静脉反流者并发症风险增加,审慎决策。
核心结论
- 合并深静脉反流患者接受主干静脉腔内消融后症状总改善无显著差异,但 VCSS 改善更大。
- 合并深静脉反流者并发症发生率显著增加,且独立于混杂因素。
研究设计与样本
- 基于 Vascular Quality Initiative 2015–2019 年数据,纳入 4881 例接受主干静脉腔内消融的患者。
- 其中 2254 例(46.2%)合并深静脉和浅静脉反流,中位随访 336.5 天。
- 采用 t 检验、χ2 或非参数检验进行术前术后比较,多变量 logistic 回归评估混杂。
主要发现
- 合并深静脉反流者女性比例更低(65.9% vs 69.9%;P = .003),白人比例更高(90.2% vs 86.5%;P = .003)。
- 无深静脉反流者术前 VCSS 中位数更高(8 vs 7;P = .005),术后 VCSS 也更高(5 vs 4;P < .001)。
- 无深静脉反流者 VCSS 中位变化更低(3 vs 3.5;P = .006)。
- 无深静脉反流者术前症状总评分更高(14 vs 13.5;P = .005),术后也更高(4 vs 3.25;P < .001),但症状评分变化无差异(8 vs 9;P = .172)。
- 合并深静脉反流者并发症发生率更高(10.4% vs 3.0%;P < .001),近端血栓延伸更多(3.1% vs 1.1%;P < .001);校正混杂后 OR 5.72(95%CI 2.21–14.81;P < .001)。
临床怎么用
- 对合并深静脉反流患者行主干静脉腔内消融前,应告知并发症风险增加,审慎决策。
- 术后需关注近端血栓延伸等并发症,及时评估和处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Few studies have investigated outcomes after truncal endovenous ablation in patients with combined deep and superficial reflux and no studies have evaluated patient-reported outcomes. METHODS: We investigated the short- and long-term clinical and patient-reported outcomes among patients with and without deep venous reflux undergoing truncal endovenous ablation from 2015 to 2019 in the Vascular Quality Initiative. Preprocedural and postprocedural comparisons were performed using the t-test, χ2, or their nonparametric counterpart when appropriate. Multivariable logistic regression models were used to assess for confounding. RESULTS: A total of 4881 patients were included, of which 2254 (46.2%) had combined deep and superficial reflux. The median follow-up was 336.5 days. Patients with deep reflux were less likely to be female (65.9% vs 69.9%; P = .003), more likely to be Caucasian (90.2% vs 86.5%; P = .003) and had no difference in BMI (30.6 ± 7.5 vs 30.6 ± 7.2; P = .904). Additionally, no difference was seen in rates of prior varicose vein treatments, number of pregnancies, or history of deep venous thrombosis; however, patients without deep reflux were more likely to be on anticoagulation at the time of the procedure (10.9% vs 8.1%; P < .001). Patients without deep reflux had slightly higher median preprocedural Venous Clinical Severity Score (VCSS) scores (8 [interquartile range (IQR), 6-10]) vs 7 [IQR, 6-10]; P = .005) as well as postprocedural VCSS scores (5 [IQR, 3-7] vs 4 [IQR, 2-6]; P < .001). The median change in VCSS from before to after the procedure was lower for patients without deep reflux (3 [IQR, 1.0-5.5] vs 3.5 [IQR, 1-6]; P = .006). Total symptom score was higher for patients without deep reflux both before (median, 14 [IQR, 10-19] vs median, 13.5 [IQR, 9.5-18]; P = .005) and postprocedurally (median, 4 [IQR, 1-9] vs median, 3.25 [IQR, 1-7]; P < .001), but no difference was seen in change in symptom score (median, 8 [IQR, 4-13] vs median, 9 [IQR, 4-13]; P = .172). Patients with deep reflux had substantially higher rates of complications (10.4% vs 3.0%; P < .001), with a particular increase in proximal thrombus extension (3.1% vs 1.1%; P < .001). After controlling for confounding, this estimate of effect size for any complication increased (odds ratio, 5.72; 95% confidence interval, 2.21-14.81; P < .001). CONCLUSIONS: No significant difference is seen in total symptom improvement when patients undergo truncal endovenous ablation with concomitant deep venous reflux, although a greater improvement was seen in VCSS score in these patients. Patients with deep venous reflux had a significantly increased rate of complications, independent of confounding variables, and should be counseled appropriately before the decision for treatment.
引用
- Brown CS, Osborne NH, Kim GY, et al. Effect of concomitant deep venous reflux on truncal endovenous ablation outcomes in the Vascular Quality Initiative. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32592853. doi:10.1016/j.jvsv.2020.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。